DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

189.53 0.57 (0.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $189.53 0.30%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $189.04
Previous Close $188.96
Daily Range $187.68 - $191.56
52-Week Range $126.08 - $203.30
Market Cap $37.6B
P/E Ratio 78.73
Dividend (Yield) $0.00 (0.0%)
Volume 2,087,585
Average Daily Volume 988,634
Current FY EPS $4.72

Sector

Healthcare

Industry

Drugs

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary

The Market's 10 Best Stocks

Look back a decade, and you'll find that nearly all the top-performing stocks have one thing in common.

Alexion's Rare Disease Model Analyzed

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results -

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog

Insider Trading Alert - DXCM, ALXN And FRGI Traded By Insiders

3 Companies Growing Faster Than MannKind Corporation

MannKind may be on the precipice of growth surge thanks to Afrezza, but these three biotech stocks are still growing faster than MannKind.

Alexion Announces New Share Repurchase Program of $500M - Analyst Blog

Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog

The New #47 Most Shorted Nasdaq 100 Component: Alexion Pharmaceuticals

ChemoCentryx: Can It Break Into The Soliris Market?

Are Investors Signaling Optimism in Biotechs Through Short Interest?

See More ALXN News...

ALXN's Top Competitors

ALXN $189.53 (0.30%)
Current stock: ALXN
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB